SOURCE: Endexx Corporation
CAVE CREEK, AZ--(Marketwired - May 28, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today it has engaged the services of Anton & Chia LLP, the largest West Coast public accounting firm (http://www.ancsecservices.com/anton-chia-llp-becomes-the-largest-west-coast-pcaob-audit-firm/), as its independent auditor. Anton & Chia will audit Endexx's financial statements from fiscal 2012, ended September 30, 2012, through March 31, 2014, the second quarter of fiscal 2014.
Todd Davis, CEO Endexx stated, "Transparency, compliance and accountability are principles on which our company operates, and are a driving force behind the technology and services we provide to the cannabis industry. Hiring a leading audit firm with experience in software and life sciences will allow Endexx to provide investors with the transparency they need to make sound decisions. Additionally, this will lay the groundwork for uplisting to a major exchange when our growth permits. In the meantime, we will be working with our audit and legal teams to meet the OTCQB standards."
The objective of the financial statement audit is the expression of an opinion about whether such financial statements are fairly presented, in all material respects, in conformity with accounting principles generally accepted in the U.S. ("GAAP"). Our audit will be conducted in accordance with the standards established by the Public Company Accounting Oversight Board ("PCAOB"), and will include tests of the Company's accounting records. The initial goal for Endexx is to qualify under OTCQB standards as a fully reporting company, elevating our degree of transparency.
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 -- the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com, www.autospense.com
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.